636 related articles for article (PubMed ID: 22182839)
21. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
Scrocchi LA; Marshall BA; Cook SM; Brubaker PL; Drucker DJ
Diabetes; 1998 Apr; 47(4):632-9. PubMed ID: 9568697
[TBL] [Abstract][Full Text] [Related]
22. Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
Flamez D; Gilon P; Moens K; Van Breusegem A; Delmeire D; Scrocchi LA; Henquin JC; Drucker DJ; Schuit F
Diabetes; 1999 Oct; 48(10):1979-86. PubMed ID: 10512362
[TBL] [Abstract][Full Text] [Related]
23. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice.
Maida A; Lamont BJ; Cao X; Drucker DJ
Diabetologia; 2011 Feb; 54(2):339-49. PubMed ID: 20972533
[TBL] [Abstract][Full Text] [Related]
24. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.
Waget A; Cabou C; Masseboeuf M; Cattan P; Armanet M; Karaca M; Castel J; Garret C; Payros G; Maida A; Sulpice T; Holst JJ; Drucker DJ; Magnan C; Burcelin R
Endocrinology; 2011 Aug; 152(8):3018-29. PubMed ID: 21673098
[TBL] [Abstract][Full Text] [Related]
25. The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs.
Smith EP; An Z; Wagner C; Lewis AG; Cohen EB; Li B; Mahbod P; Sandoval D; Perez-Tilve D; Tamarina N; Philipson LH; Stoffers DA; Seeley RJ; D'Alessio DA
Cell Metab; 2014 Jun; 19(6):1050-7. PubMed ID: 24836562
[TBL] [Abstract][Full Text] [Related]
26. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
Pederson RA; Satkunarajah M; McIntosh CH; Scrocchi LA; Flamez D; Schuit F; Drucker DJ; Wheeler MB
Diabetes; 1998 Jul; 47(7):1046-52. PubMed ID: 9648827
[TBL] [Abstract][Full Text] [Related]
27. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
[TBL] [Abstract][Full Text] [Related]
28. A novel humanized GLP-1 receptor model enables both affinity purification and Cre-LoxP deletion of the receptor.
Jun LS; Showalter AD; Ali N; Dai F; Ma W; Coskun T; Ficorilli JV; Wheeler MB; Michael MD; Sloop KW
PLoS One; 2014; 9(4):e93746. PubMed ID: 24695667
[TBL] [Abstract][Full Text] [Related]
29. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
[TBL] [Abstract][Full Text] [Related]
30. Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with
Esser N; Mongovin SM; Parilla J; Barrow BM; Mundinger TO; Fountaine BS; Larmore MJ; Castillo JJ; Akter R; Hull RL; Zraika S
Am J Physiol Endocrinol Metab; 2022 Mar; 322(3):E307-E318. PubMed ID: 35128957
[TBL] [Abstract][Full Text] [Related]
31. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
Flamez D; Van Breusegem A; Scrocchi LA; Quartier E; Pipeleers D; Drucker DJ; Schuit F
Diabetes; 1998 Apr; 47(4):646-52. PubMed ID: 9568699
[TBL] [Abstract][Full Text] [Related]
32. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.
Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB
Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020
[TBL] [Abstract][Full Text] [Related]
33. GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms.
Flock G; Holland D; Seino Y; Drucker DJ
Endocrinology; 2011 Feb; 152(2):374-83. PubMed ID: 21068156
[TBL] [Abstract][Full Text] [Related]
34. Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function.
Renner S; Fehlings C; Herbach N; Hofmann A; von Waldthausen DC; Kessler B; Ulrichs K; Chodnevskaja I; Moskalenko V; Amselgruber W; Göke B; Pfeifer A; Wanke R; Wolf E
Diabetes; 2010 May; 59(5):1228-38. PubMed ID: 20185813
[TBL] [Abstract][Full Text] [Related]
35. SUMO downregulates GLP-1-stimulated cAMP generation and insulin secretion.
Rajan S; Torres J; Thompson MS; Philipson LH
Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E714-23. PubMed ID: 22234371
[TBL] [Abstract][Full Text] [Related]
36. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action.
Ayala JE; Bracy DP; James FD; Julien BM; Wasserman DH; Drucker DJ
Endocrinology; 2009 Mar; 150(3):1155-64. PubMed ID: 19008308
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats.
Vahl TP; Tauchi M; Durler TS; Elfers EE; Fernandes TM; Bitner RD; Ellis KS; Woods SC; Seeley RJ; Herman JP; D'Alessio DA
Endocrinology; 2007 Oct; 148(10):4965-73. PubMed ID: 17584962
[TBL] [Abstract][Full Text] [Related]
38. The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 engages the glucagon-like peptide-1 incretin hormone axis to lower levels of blood glucose in db/db mice.
Meng Q; Chepurny OG; Leech CA; Pruekprasert N; Molnar ME; Collier JJ; Cooney RN; Holz GG
Diabetes Obes Metab; 2022 Jul; 24(7):1255-1266. PubMed ID: 35293666
[TBL] [Abstract][Full Text] [Related]
39. SAD-A potentiates glucose-stimulated insulin secretion as a mediator of glucagon-like peptide 1 response in pancreatic β cells.
Nie J; Lilley BN; Pan YA; Faruque O; Liu X; Zhang W; Sanes JR; Han X; Shi Y
Mol Cell Biol; 2013 Jul; 33(13):2527-34. PubMed ID: 23629625
[TBL] [Abstract][Full Text] [Related]
40. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.
Shu L; Matveyenko AV; Kerr-Conte J; Cho JH; McIntosh CH; Maedler K
Hum Mol Genet; 2009 Jul; 18(13):2388-99. PubMed ID: 19386626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]